Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development-a narrative review

Santarpia, M; Ciappina, G; Spagnolo, CC; Squeri, A; Passalacqua, MI; Aguilar, A; Gonzalez-Cao, M; Giovannetti, E; Silvestris, N; Rosell, R

Santarpia, M (通讯作者)，Univ Messina, Dept Human Pathol G Barresi, Med Oncol Unit, Via Consolare Valeria 1, I-98122 Messina, Italy.;Rosell, R (通讯作者)，Dexeus Univ Hosp, Oncol Inst Dr Rosell, IOR, Oncol Inst Dr, Calle Sabino Arana, 5, Barcelona 08028, Spain.

TRANSLATIONAL LUNG CANCER RESEARCH, 2023; 12 (2): 346

Abstract

Background and Objective: Non-small cell lung cancer (NSCLC) with Kirsten rat sarcoma viral oncogene homolog (KRAS) driver alterations harbors a poor ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索